A carregar...
ACTR-29. A SERIES OF PATIENTS (PTS) WITH RECURRENT GBM (rGBM) TREATED WITH ABT-414, BEVACIZUMAB (BEV) AND CCNU
BACKGROUND: ABT-414 showed encouraging results in the phase 2 Intellance 2 rGBM study, but not in the phase 3 Intellance 1 trial, in newly diagnosed EGFR-amplified GBM. We describe a series of pts with rGBM treated with ABT-414 in combination with Bev and CCNU. METHODS: A retrospective review of pts...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6847034/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.072 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|